Evidence map›Paper›PMID 34757124›Full record

ArticleKidney international2022

Deep learning identified pathological abnormalities predictive of graft loss in kidney transplant biopsies.

Zhengzi Yi, Fadi Salem, Madhav C Menon, Karen Keung, Caixia Xi, Sebastian Hultin, M Rizwan Haroon Al Rasheed, Li Li, Fei Su, Zeguo Sun and 16 more

Open access · bronzeAbstract read
In one paragraph

Article in Kidney international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. How Close Are We? Limitations and Progress of AI Models in Banff Lesion Scoring.Proceedings of SPIE--the International Society for Optical Engineering · 2026
    Article
  10. Article
  11. Review
  12. Observational
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. [Artificial intelligence in kidney transplant pathology].Pathologie (Heidelberg, Germany) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 4 institutions in 2 countries.

Zhengzi YiRenal Division, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Fadi SalemPathology Division, Department of Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Madhav C MenonRenal Division, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Nephrology Division, Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Karen KeungCentre for Transplant and Renal Research, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia; Department of Nephrology, Prince of Wales Hospital, Sydney, New South Wales, Australia.
Caixia XiRenal Division, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Sebastian HultinCentre for Transplant and Renal Research, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.
M Rizwan Haroon Al RasheedPathology Division, Department of Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Li LiPathology Division, Department of Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Fei SuRenal Division, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Zeguo SunRenal Division, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Chengguo WeiRenal Division, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Weiqing HuangRenal Division, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Samuel FredericksRenal Division, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Qisheng LinNephrology Division, Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Khadija BanuNephrology Division, Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Germaine WongCentre for Transplant and Renal Research, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.
Natasha M RogersCentre for Transplant and Renal Research, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.
Samira FaroukRenal Division, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Paolo CravediRenal Division, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Meena ShingdeCentre for Transplant and Renal Research, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.
R Neal SmithDepartment of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA; Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA.
Ivy A RosalesDepartment of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA; Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA.
Philip J O'ConnellCentre for Transplant and Renal Research, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia; Department of Nephrology, Westmead Hospital, Sydney, New South Wales, Australia.
Robert B ColvinDepartment of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA; Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA.
Barbara MurphyRenal Division, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Weijia ZhangRenal Division, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: weijia.zhang@mssm.edu.
Icahn School of Medicine at Mount Sinai · USThe University of Sydney · AUHarvard University · USYale University · US

Funding

Genomics of Chronic Renal Allograft RejectionU01AI070107 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MURPHY, BARBARA T. · 2006 to 2012
$9.4M
Dichotomous roles of Shroom3 in Tubular cells and Podocytes in native and allograft kidneysR01DK122164 · NIDDK · YALE UNIVERSITY · PI Madhav C Menon · 2019 to 2026
$2.7M
Role of AMP-kinase pathway in the regulation of Minimal change disease-to-FSGS transitionR01DK132274 · NIDDK · YALE UNIVERSITY · PI Madhav C Menon · 2023 to 2026
$2.1M
NIAID NIH HHS U01 AI070107NIDDK NIH HHS R01 DK122164NIDDK NIH HHS R01 DK132274
6 · The paper itself

Abstract

Interstitial fibrosis, tubular atrophy, and inflammation are major contributors to kidney allograft failure. Here we sought an objective, quantitative pathological assessment of these lesions to improve predictive utility and constructed a deep-learning-based pipeline recognizing normal vs. abnormal kidney tissue compartments and mononuclear leukocyte infiltrates. Periodic acid- Schiff stained slides of transplant biopsies (60 training and 33 testing) were used to quantify pathological lesions specific for interstitium, tubules and mononuclear leukocyte infiltration. The pipeline was applied to the whole slide images from 789 transplant biopsies (478 baseline [pre-implantation] and 311 post-transplant 12-month protocol biopsies) in two independent cohorts (GoCAR: 404 patients, AUSCAD: 212 patients) of transplant recipients to correlate composite lesion features with graft loss. Our model accurately recognized kidney tissue compartments and mononuclear leukocytes. The digital features significantly correlated with revised Banff 2007 scores but were more sensitive to subtle pathological changes below the thresholds in the Banff scores. The Interstitial and Tubular Abnormality Score (ITAS) in baseline samples was highly predictive of one-year graft loss, while a Composite Damage Score in 12-month post-transplant protocol biopsies predicted later graft loss. ITASs and Composite Damage Scores outperformed Banff scores or clinical predictors with superior graft loss prediction accuracy. High/intermediate risk groups stratified by ITASs or Composite Damage Scores also demonstrated significantly higher incidence of estimated glomerular filtration rate decline and subsequent graft damage. Thus, our deep-learning approach accurately detected and quantified pathological lesions from baseline or post-transplant biopsies and demonstrated superior ability for prediction of post-transplant graft loss with potential application as a prevention, risk stratification or monitoring tool.

Indexed as

Deep LearningKidney TransplantationBiopsyGraft RejectionGraft SurvivalHumansKidneydeep learninggraft survivalkidney transplantationrenal pathology

Identifiers

PMID34757124
PMCPMC10285669
OpenAlexW3154045578

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.